Scholarlink

Background <p>Lipid metabolic dysregulation contributes to cardiovascular disease, yet its role in high-altitude heart disease (HAHD) remains unclear.</p> Methods <p>We enrolled 525 high-altitude immigrants and 98 plain controls. Cardiac function and serum lipids were clinically assessed. Untargeted lipidomics was performed to profile circulating lipids in a matched discovery subgroup (<i>N</i> = 15 per group): plain controls, high-altitude residents with normal cardiac function, and high-altitude residents with cardiac dysfunction. Correlation analyses identified lipids linked to myocardial injury biomarkers. ROC analysis evaluated diagnostic potential.</p> Results <p>Cardiac dysfunction prevalence was 46.4% in high-altitude subjects and correlated with hyperlipidemia. Lipidomics revealed HAHD-specific remodeling characterized by increased glycerolipids (e.g., triglycerides, diglycerides) and free fatty acids, alongside decreased sphingolipids (ceramides, hexosylceramides) and phospholipids (phosphatidylserine, phosphatidic acid). Twenty-five lipids were associated with myocardial injury biomarkers, of which eight, notably PS(20:4_20:4) and DG(16:0_20:4), showed good discriminatory performance (AUC &gt; 0.8 in the matched group). These lipids correlated with immune traits, suggesting lipid-immune crosstalk.</p> Conclusion <p>This study identifies a distinct lipid signature in HAHD and implicates lipid-immune interactions in disease progression. These exploratory findings provide mechanistic insights and warrant further validation as potential biomarkers for early detection and targeted intervention of high-altitude cardiac dysfunction in future independent cohorts.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lipid profile shift in high-altitude migrants as a key promoting factor for chronic myocardial injury revealed by lipidomics

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年5月1日

查看全文
  • Huifang Deng,
  • Pan Shen,
  • Gaofu Li,
  • Zifei Yin,
  • Lei Zhou,
  • Zhijie Bai,
  • Pengfei Zhang,
  • Yongqiang Zhou,
  • Ningning Wang,
  • Yue Gao,
  • Wei Zhou

摘要

Background

Lipid metabolic dysregulation contributes to cardiovascular disease, yet its role in high-altitude heart disease (HAHD) remains unclear.

Methods

We enrolled 525 high-altitude immigrants and 98 plain controls. Cardiac function and serum lipids were clinically assessed. Untargeted lipidomics was performed to profile circulating lipids in a matched discovery subgroup (N = 15 per group): plain controls, high-altitude residents with normal cardiac function, and high-altitude residents with cardiac dysfunction. Correlation analyses identified lipids linked to myocardial injury biomarkers. ROC analysis evaluated diagnostic potential.

Results

Cardiac dysfunction prevalence was 46.4% in high-altitude subjects and correlated with hyperlipidemia. Lipidomics revealed HAHD-specific remodeling characterized by increased glycerolipids (e.g., triglycerides, diglycerides) and free fatty acids, alongside decreased sphingolipids (ceramides, hexosylceramides) and phospholipids (phosphatidylserine, phosphatidic acid). Twenty-five lipids were associated with myocardial injury biomarkers, of which eight, notably PS(20:4_20:4) and DG(16:0_20:4), showed good discriminatory performance (AUC > 0.8 in the matched group). These lipids correlated with immune traits, suggesting lipid-immune crosstalk.

Conclusion

This study identifies a distinct lipid signature in HAHD and implicates lipid-immune interactions in disease progression. These exploratory findings provide mechanistic insights and warrant further validation as potential biomarkers for early detection and targeted intervention of high-altitude cardiac dysfunction in future independent cohorts.